Neutral
Last updated: 2026-10-04 23:54:50 ET
From the street swagger of Oasis to the epic alienation of Radiohead, the spaced-out futurism of Massive Attack to the technotronic shock waves of the...
Elevance Health has delivered a 12.4% gain over the past year, even as shorter term moves have been choppy, and that raises a simple question for you as an investor. Is the current share price of the health benefits group adequately grounded in the e...
Elevra Lithium (ASX: ELV; Nasdaq: ELVR) has started building a $366-million (US$271-million) expansion of its North American Lithium mine in Quebec an...
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%...
INDIANAPOLIS, October 01, 2026--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler ben...
Elevance Health (ELV) drew fresh attention after its recent share move, with the price closing at US$388.82. Investors are weighing this healthcare insurer’s valuation against its mixed short and longer term return profile. Recent trading has been ...
Fed officials are sending mixed signals on rate hikes, Treasury yields have eased, and crucial data is about to hit, which puts high quality U.S. large caps in the spotlight. Investors hunting for a steadier ride may not want to wait until the next F...
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Wheth...
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Wheth...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE